POAS
Phaos Technology Holdings (Caym (AMEX)
Healthcare — Medical Devices
Phaos Technology Holdings (Cayman) Limited, through its subsidiary, Phaos Technology Pte. Ltd., engages in the manufacturing and commercialization of advanced microscopy-related solutions, technologies, and products in Singapore. The company offers Optonano that enables users to view live and still images for construction of high-quality image of larger sample areas; PT-Industrial for use in material study, failure analysis, simple measuring, quality control, inspection, and manufacturing; and PT-Metrology, which provides dimensional measurements with a single key operation. It also provides PT-Biology to create specialized images needed in the biomedical sector; PT-Stereo, a stereo microscope designed to provide clear magnified stereoscopic images that amplify solid or thick samples; and PT-Zoom that offers three-dimensional magnified view of samples to enhance visualization. In addition, the company offers software. The company serves manufacturing companies; biomedical service providers; and research and development institutions. The company was founded in 2017 and is based in Singapore.
Price History
Fundamentals
| Market Cap | $5.16M |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | $-0.27 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 38.80% |
| ROE | - |
| Debt/Equity | - |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Indexes | AMEX |
Technical Indicators
| RSI (14) | 49.7 |
| Beta | - |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $7.40 |
| 52-Week Low | $0.25 |
| 50-Day Avg | $1.42 |
| 200-Day Avg | $2.47 |
| Avg Volume | $1.40M |
| Volume | 673.1K |
Performance Analysis
NEUTRALPOAS presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Jul 02, 2026 13:27 UTC
Back to Screener Export Report